UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Australian comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein (Eloctate®)

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-09, Vol.26 (5), p.e226-e229

2020

Volltextzugriff (PDF)

BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report

BMC infectious diseases, 2023-09, Vol.23 (1), p.1-609, Article 609

2023

Volltextzugriff (PDF)

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Journal of thrombosis and haemostasis, 2023-12, Vol.21 (12), p.3450-3462

2023

Volltextzugriff (PDF)

The presence of F cells with a fetal phenotype in adults with hemoglobinopathies limits the utility of flow cytometry for quantitation of fetomaternal hemorrhage

Cytometry. Part B, Clinical cytometry, 2018-07, Vol.94 (4), p.695-698

2018

Volltextzugriff (PDF)

Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation

Cell, 2013-08, Vol.154 (3), p.583-595

2013

Volltextzugriff (PDF)

082 Fulminant ADEM mimicking a glial tumour

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A30-A30

2021

Volltextzugriff (PDF)

Emicizumab assay evaluations and results from an Australian field study of emicizumab measurement

Pathology, 2022-10, Vol.54 (6), p.755-762

2022

Volltextzugriff (PDF)

Metachronous chronic myeloid leukaemia occurring with background multiple myeloma

Pathology, 2020-04, Vol.52 (3), p.377-379

2020

Volltextzugriff (PDF)

Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine

Leukemia & lymphoma, 2020-01, Vol.61 (2), p.477-480

2020

Volltextzugriff (PDF)

The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo

Journal of hematology and oncology, 2017-03, Vol.10 (1), p.75-75, Article 75

2017

Volltextzugriff (PDF)

Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B

Journal of gastroenterology and hepatology, 2007-09, Vol.22 (9), p.1500-1505

2007

Volltextzugriff (PDF)

Blood transfusion is a rare but potential source of false-positive phosphatidylethanol

Liver transplantation, 2024-08, Vol.30 (8), p.866-868

2024

Volltextzugriff (PDF)

Interferon-alpha in the treatment of multiple myeloma

Current drug targets, 2011-03, Vol.12 (3), p.437

2011

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.494-502

2020

Volltextzugriff (PDF)

Case report of a fatal rectal haemorrhage in a person with severe haemophilia A receiving emicizumab and high‐dose bypassing agents in the HAVEN 1 study

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.e340-e342

2020

Volltextzugriff (PDF)

Complex head and neck microsurgery/neurosurgery in Gray platelet syndrome

ANZ journal of surgery, 2023-05, Vol.93 (5), p.1388-1389

2023

Volltextzugriff (PDF)

Metachronous chronic myeloid leukaemia occurring with background multiple myeloma – a case report

Pathology, 2019-02, Vol.51, p.S128-S128

2019

Volltextzugriff (PDF)

Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT

Leukemia & lymphoma, 2013-01, Vol.54 (1), p.186-188

2013

Volltextzugriff (PDF)

Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)

Blood, 2021-12, Vol.138 (Supplement 2), p.LBA-3-LBA-3

2021

Volltextzugriff (PDF)

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Thrombosis and haemostasis, 2021-10, Vol.121 (10), p.1326

2021

Volltextzugriff (PDF)

Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state

Leukemia & lymphoma, 2014-05, Vol.55 (5), p.1090-1098

2014

Volltextzugriff (PDF)

Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial

The Lancet. Haematology, 2023-05, Vol.10 (5), p.e322-e332

2023

Volltextzugriff (PDF)

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

Blood, 2018-11, Vol.132 (Supplement 1), p.2480-2480

2018

Volltextzugriff (PDF)

Safety and Efficacy of R-CEEP (Rituximab, Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) in Elderly or Unfit Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Single-Centre Experience

Blood, 2019-11, Vol.134 (Supplement_1), p.2911-2911

2019

Volltextzugriff (PDF)

Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study

Blood, 2017-12, Vol.130, p.3668-3668

2017

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)
Berichte
(4)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Australian comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein (Eloctate®)

BK viraemia as a cause of anaemia in after ABO-incompatible liver transplant: a case report

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

The presence of F cells with a fetal phenotype in adults with hemoglobinopathies limits the utility of flow cytometry for quantitation of fetomaternal hemorrhage

Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation

082 Fulminant ADEM mimicking a glial tumour

Emicizumab assay evaluations and results from an Australian field study of emicizumab measurement

Metachronous chronic myeloid leukaemia occurring with background multiple myeloma

Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine

The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo

Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B

Blood transfusion is a rare but potential source of false-positive phosphatidylethanol

Interferon-alpha in the treatment of multiple myeloma

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

Case report of a fatal rectal haemorrhage in a person with severe haemophilia A receiving emicizumab and high‐dose bypassing agents in the HAVEN 1 study

Complex head and neck microsurgery/neurosurgery in Gray platelet syndrome

Metachronous chronic myeloid leukaemia occurring with background multiple myeloma – a case report

Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT

Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state

Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

Safety and Efficacy of R-CEEP (Rituximab, Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) in Elderly or Unfit Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Single-Centre Experience

Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study

Suchergebnisse filtern